APOBEC3G and HIV-1 infection: Given that A3G exerts potent anti-HIV activity which is neutralized by the HIV-1 Vif protein, characterization of the A3G-Vif interaction is of considerable interest, as it provides a target for novel therapeutic strategies against HIV-1 infection.